Korean J Urol.  2015 Apr;56(4):266-275. 10.4111/kju.2015.56.4.266.

A current perspective on geriatric lower urinary tract dysfunction

• Jung HB
• Kim HJ
• Cho ST

• KMID: 2155301
• DOI: http://doi.org/10.4111/kju.2015.56.4.266

Abstract

Lower urinary tract dysfunction-such as urinary incontinence (UI), detrusor overactivity, and benign prostatic hyperplasia-is prevalent in elderly persons. These conditions can interfere with daily life and normal functioning and lead to negative effects on health-related quality of life. UI is one of the most common urologic conditions but is poorly understood elderly persons. The overall prevalence of UI increases with age in both men and women. Elderly persons often neglect UI or dismiss it as part of the normal aging process. However, UI can have significant negative effects on self-esteem and has been associated with increased rates of depression. UI also affects quality of life and activities of daily living. Although UI is more common in elderly than in younger persons, it should not be considered a normal part of aging. UI is abnormal at any age. The goal of this review is to provide an overview of the cause, classification, evaluation, and management of geriatric lower urinary tract dysfunction.

Keyword

Aged; Lower urinary tract symptoms; Urinary bladder; Urinary incontinence

MeSH Terms

Activities of Daily Living
Aged
*Aging/physiology/psychology
Disease Management
Female
Humans
Male
Prevalence
*Quality of Life
Urinary Tract/*physiopathology
*Urologic Diseases/classification/epidemiology/etiology/physiopathology/psychology/therapy

Reference

1. Ezeh AC, Bongaarts J, Mberu B. Global population trends and policy options. Lancet. 2012; 380:142–148.

2. Ory MG, Wyman JF, Yu L. Psychosocial factors in urinary incontinence. Clin Geriatr Med. 1986; 2:657–671.

3. Collerton J, Davies K, Jagger C, Kingston A, Bond J, Eccles MP, et al. Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ. 2009; 339:b4904.

4. Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, et al. Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol. 2012; 53:342–348.

5. Naughton MJ, Wyman JF. Quality of life in geriatric patients with lower urinary tract dysfunction. Am J Med Sci. 1997; 314:219–227.

6. Chutka DS, Fleming KC, Evans MP, Evans JM, Andrews KL. Urinary incontinence in the elderly population. Mayo Clin Proc. 1996; 71:93–101.

7. Griebling TL. Urinary incontinence in the elderly. Clin Geriatr Med. 2009; 25:445–457.

8. Jeter KF, Wagner DB. Incontinence in the American home. A survey of 36,500 people. J Am Geriatr Soc. 1990; 38:379–383.

9. Johnson TM 2nd, Kincade JE, Bernard SL, Busby-Whitehead J, Hertz-Picciotto I, DeFriese GH. The association of urinary incontinence with poor self-rated health. J Am Geriatr Soc. 1998; 46:693–699.

10. Dugan E, Cohen SJ, Bland DR, Preisser JS, Davis CC, Suggs PK, et al. The association of depressive symptoms and urinary incontinence among older adults. J Am Geriatr Soc. 2000; 48:413–416.

11. Grimby A, Milsom I, Molander U, Wiklund I, Ekelund P. The influence of urinary incontinence on the quality of life of elderly women. Age Ageing. 1993; 22:82–89.

12. Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000; 6:S580–S590.

13. Griebling TL. Geriatric urology. In : Solomon DH, LoCicero J, Rosenthal RA, editors. New frontiers in geriatric research: an agenda for surgical and related medical specialties. New York: American Geriatric Society;2004. p. 269–302.

14. Lawhorne LW, Ouslander JG, Parmelee PA, Resnick B, Calabrese B. Urinary incontinence: a neglected geriatric syndrome in nursing facilities. J Am Med Dir Assoc. 2008; 9:29–35.

15. Resnick NM, Tadic SD, Yalla SV. Campbell-Walsh urology. In : Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Geriatric incontinence and voiding dysfunction. 10th ed. Philadelphia: Saunders;2012. p. 2201–2222.

16. Tong YC. Diagnosis and treatment of geriatric urinary incontinence. Incont Pelvic Floor Dysfunct. 2009; 3:69–72.

17. Pfisterer MH, Griffiths DJ, Schaefer W, Resnick NM. The effect of age on lower urinary tract function: a study in women. J Am Geriatr Soc. 2006; 54:405–412.

18. Trowbridge ER, Wei JT, Fenner DE, Ashton-Miller JA, Delancey JO. Effects of aging on lower urinary tract and pelvic floor function in nulliparous women. Obstet Gynecol. 2007; 109:715–720.

19. Betschart C, Scheiner D, Maake C, Vich M, Slomianka L, Fink D, et al. Histomorphological analysis of the urogenital diaphragm in elderly women: a cadaver study. Int Urogynecol J Pelvic Floor Dysfunct. 2008; 19:1477–1481.

20. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002; 21:167–178.

21. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010; 29:4–20.

22. Herzog AR, Fultz NH. Prevalence and incidence of urinary incontinence in community-dwelling populations. J Am Geriatr Soc. 1990; 38:273–281.

23. Diokno AC, Lajiness MJ, Griebling TL. Geriatric urology. In : Griebling TL, editor. Urinary incontinence: evaluation and diagnosis. New York: Springer;2013. p. 127–139.

24. Greer JA, Arya LA, Smith AL. Urinary incontinence: diagnosis and treatment in the elderly. Curr Transl Geriatr and Exp Gerontol Rep. 2013; 2:66–75.

25. Lee SH, Cho ST, Na HR, Ko SB, Park MH. Urinary incontinence in patients with Alzheimer's disease: relationship between symptom status and urodynamic diagnoses. Int J Urol. 2014; 21:683–687.

26. Na HR, Park MH, Cho ST, Lee BC, Park S, Kim KH, et al. Urinary incontinence in Alzheimer's disease is associated with Clinical Dementia Rating-Sum of Boxes and Barthel Activities of Daily Living. Asia Pac Psychiatry. 2015; 7:113–120.

27. Resnick NM, Yalla SV. Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients. JAMA. 1987; 257:3076–3081.

28. Taylor JA 3rd, Kuchel GA. Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc. 2006; 54:1920–1932.

29. Resnick NM, Marcantonio ER. How should clinical care of the aged differ? Lancet. 1997; 350:1157–1158.

30. Diokno AC, Brock BM, Herzog AR, Bromberg J. Medical correlates of urinary incontinence in the elderly. Urology. 1990; 36:129–138.

31. Fultz NH, Rahrig Jenkins K, Ostbye T, Taylor DH Jr, Kabeto MU, Langa KM. The impact of own and spouse's urinary incontinence on depressive symptoms. Soc Sci Med. 2005; 60:2537–2548.

32. Sung VW, West DS, Hernandez AL, Wheeler TL 2nd, Myers DL, Subak LL, et al. Association between urinary incontinence and depressive symptoms in overweight and obese women. Am J Obstet Gynecol. 2009; 200:557 e1–557 e5.

33. Bae JN, Cho MJ. Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. J Psychosom Res. 2004; 57:297–305.

34. Collins CW, Winters JC. American Urological Association. Society of Urodynamics Female Pelvic Medicine and Urogenital Reconstruction. AUA/SUFU adult urodynamics guideline: a clinical review. Urol Clin North Am. 2014; 41:353–362.

35. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012; 188:2455–2463.

36. Reynard JM, Cannon A, Yang Q, Abrams P. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol. 1998; 81:215–218.

37. Resnick NM, Brandeis GH, Baumann MM, DuBeau CE, Yalla SV. Misdiagnosis of urinary incontinence in nursing home women: prevalence and a proposed solution. Neurourol Urodyn. 1996; 15:599–613.

38. DuBeau CE, Kuchel GA, Johnson T 2nd, Palmer MH, Wagg A. Fourth International Consultation on I. Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence. Neurourol Urodyn. 2010; 29:165–178.

39. Newman DK, Burgio KL, Markland AD, Goode PS. Geriatric urology. In : Griebling TL, editor. Urinary Incontinence: nonsurgical treatment. New York: Springer;2013. p. 141–168.

40. Fantl JA, Wyman JF, McClish DK, Harkins SW, Elswick RK, Taylor JR, et al. Efficacy of bladder training in older women with urinary incontinence. JAMA. 1991; 265:609–613.

41. Fantl JA, Wyman JF, Harkins SW, Hadley EC. Bladder training in the management of lower urinary tract dysfunction in women. A review. J Am Geriatr Soc. 1990; 38:329–332.

42. Ostaszkiewicz J, Johnston L, Roe B. Timed voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev. 2004; CD002802.

43. Ostaszkiewicz J, Johnston L, Roe B. Habit retraining for the management of urinary incontinence in adults. Cochrane Database Syst Rev. 2004; CD002801.

44. Eustice S, Roe B, Paterson J. Prompted voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev. 2000; CD002113.

45. Burgio LD, Engel BT, Hawkins A, McCormick K, Scheve A, Jones LT. A staff management system for maintaining improvements in continence with elderly nursing home residents. J Appl Behav Anal. 1990; 23:111–118.

46. Engel BT, Burgio LD, McCormick KA, Hawkins AM, Scheve AA, Leahy E. Behavioral treatment of incontinence in the longterm care setting. J Am Geriatr Soc. 1990; 38:361–363.

47. Tannenbaum C, DuBeau CE. Urinary incontinence in the nursing home: practical approach to evaluation and management. Clin Geriatr Med. 2004; 20:437–452.

48. Lucas MG, Bosch RJ, Burkhard FC, Cruz F, Madden TB, Nambiar AK, et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2012; 62:1130–1142.

49. Burgio KL, Goode PS, Locher JL, Umlauf MG, Roth DL, Richter HE, et al. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. JAMA. 2002; 288:2293–2299.

50. Burgio KL, Locher JL, Goode PS, Hardin JM, McDowell BJ, Dombrowski M, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA. 1998; 280:1995–2000.

51. Alhasso AA, McKinlay J, Patrick K, Stewart L. Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2006; CD003193.

52. Schiffers M, Sauermann P, Schurch B, Mehnert U. The effect of tolterodine 4 and 8 mg on the heart rate variability in healthy subjects. World J Urol. 2010; 28:651–656.

53. Gopal M, Haynes K, Bellamy SL, Arya LA. Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstet Gynecol. 2008; 112:1311–1318.

54. Kessler TM, Bachmann LM, Minder C, Lohrer D, Umbehr M, Schunemann HJ, et al. Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS One. 2011; 6:e16718.

55. Sakakibara R, Uchiyama T, Yamanishi T, Kishi M. Dementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population. Int J Urol. 2008; 15:778–788.

56. Johnell K, Fastbom J. Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients. Drugs Aging. 2008; 25:871–877.

57. Igawa Y, Michel MC. Pharmacological profile of beta3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome. Naunyn Schmiedebergs Arch Pharmacol. 2013; 386:177–183.

58. Wolff GF, Kuchel GA, Smith PP. Overactive bladder in the vulnerable elderly. Res Rep Urol. 2014; 6:131–138.

59. Tyagi P, Thomas CA, Yoshimura N, Chancellor MB. Investigations into the presence of functional Beta1, Beta2 and Beta3-adrenoceptors in urothelium and detrusor of human bladder. Int Braz J Urol. 2009; 35:76–83.

60. Wagg AS, Cardozo L, Chapple C, De Ridder D, Kelleher C, Kirby M, et al. Overactive bladder syndrome in older people. BJU Int. 2007; 99:502–509.

61. Kuo HC. Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years. Urology. 2002; 59:485–489.

62. Mangera A, Apostolidis A, Andersson KE, Dasgupta P, Giannantoni A, Roehrborn C, et al. An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders. Eur Urol. 2014; 65:981–990.

63. Cruz F, Dinis P. Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms. Neurourol Urodyn. 2007; 26:920–927.

64. Karsenty G, Denys P, Amarenco G, De Seze M, Game X, Haab F, et al. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol. 2008; 53:275–287.

65. Choi H, Palmer MH, Park J. Meta-analysis of pelvic floor muscle training: randomized controlled trials in incontinent women. Nurs Res. 2007; 56:226–234.

66. Goode PS, Burgio KL, Locher JL, Roth DL, Umlauf MG, Richter HE, et al. Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women: a randomized controlled trial. JAMA. 2003; 290:345–352.

67. Perrin L, Dauphinee SW, Corcos J, Hanley JA, Kuchel GA. Pelvic floor muscle training with biofeedback and bladder training in elderly women: a feasibility study. J Wound Ostomy Continence Nurs. 2005; 32:186–199.

68. Neumann PB, Grimmer KA, Deenadayalan Y. Pelvic floor muscle training and adjunctive therapies for the treatment of stress urinary incontinence in women: a systematic review. BMC Womens Health. 2006; 6:11.

69. Mariappan P, Alhasso A, Ballantyne Z, Grant A, N'Dow J. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol. 2007; 51:67–74.

70. Zinner NR, Koke SC, Viktrup L. Pharmacotherapy for stress urinary incontinence: present and future options. Drugs. 2004; 64:1503–1516.

71. Malek JM, Ellington DR, Jauk V, Szychowski JM, Parden AM, Richter HE. The effect of age on stress and urgency urinary incontinence outcomes in women undergoing primary midurethral sling. Int Urogynecol J. 2014; 12. 16. [Epub]. http://dx.doi.org/10.1007/s00192-014-2594-4.

72. Richter HE, Burgio KL, Chai TC, Kraus SR, Xu Y, Nyberg L, et al. Predictors of outcomes in the treatment of urge urinary incontinence in women. Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20:489–497.

73. Sharp VJ, Bradley CS, Kreder KJ. Incontinence surgery in the older woman. Curr Opin Urol. 2006; 16:224–228.

74. Gordon D, Gold R, Pauzner D, Lessing JB, Groutz A. Tensionfree vaginal tape in the elderly: is it a safe procedure? Urology. 2005; 65:479–482.

75. Hellberg D, Holmgren C, Lanner L, Nilsson S. The very obese woman and the very old woman: tension-free vaginal tape for the treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2007; 18:423–429.

76. Diokno AC, Burgio K, Fultz NH, Kinchen KH, Obenchain R, Bump RC. Prevalence and outcomes of continence surgery in community dwelling women. J Urol. 2003; 170:507–511.

77. Shamliyan TA, Kane RL, Wyman J, Wilt TJ. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med. 2008; 148:459–473.

78. Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G. Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. J Urol. 2009; 181:2634–2640.

79. Lee JY, Kim HW, Lee SJ, Koh JS, Suh HJ, Chancellor MB. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int. 2004; 94:817–820.

80. Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006; 296:2319–2328.

81. Barendrecht MM, Oelke M, Laguna MP, Michel MC. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int. 2007; 99:749–752.